Lonza
LONN
Performance
About Lonza
Lonza is a leading contract development and manufacturing organization focused on the healthcare industry. Founded in Switzerland in 1897, it operates globally with about 19,000 employees across five continents and offers integrated biologics, small molecule, specialized modalities, and regulatory services to help pharmaceutical and biotech customers bring therapies to market. The company positions itself as a pioneer in the CDMO space with capabilities spanning mammalian biologics, small molecules, cell and gene therapy, and related manufacturing and development services. Lonza serves customers worldwide, delivering life-enhancing and life-saving treatments across diverse therapeutic areas.
Recent News
Lonza Boosts Advanced Synthesis Capabilities for Bioconjugates
Scalable Biologics Production Trends: Featuring Omar Wahab of Lonza — Breakthrough, Episode 250
Sidewinder Targets Solid Tumors with Bispecific ADCs on Novartis-Backed Funding
Dietary Fructo-Oligosaccharides Dose-Dependently Modulate the Microbiome and Suppress Type 2 Lung Inflammation in a Murine Model of House Dust Mite-Induced Allergic Asthma